New Treatments for epitheliod inflammatory myofibroblastic sarcoma
New Treatments for epitheliod inflammatory myofibroblastic sarcoma
上皮样炎性肌纤维母细胞肉瘤的新疗法
批准号：
nhmrc : 1144641
负责人：
Dr Greg Arndt
金额：
$43.76万
依托单位国家：
澳大利亚
项目类别：
Project Grants
财政年份：
2018
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2018-01-01 至 2021-12-31
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Epithelioid Inflammatory myofibroblastic sarcoma (eIMS) is a rare aggressive cancer, most common in of childhood and young adults. This cancer has been scarcely studied due to its rarity and is not cured by standard chemotherapeutic regimes. Our investigations will extensively characterise eIMS samples from recently diagnosed patients, and apply a new laboratory model to discover more effective drugs and improve treatment outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia
-
批准号：nhmrc : 1027831
-
项目类别：Project Grants
-
资助金额：$26.32万
-
财政年份：2012
-
负责人：Dr Greg Arndt
-
依托单位：
海外基金
